Health

U.S. FDA Approves Tablet Formulation of BeOne’s Brukinsa for All Approved Indications

DailyTrendDailyTrend
Jun 12, 2025 - 14:00
 0  0
U.S. FDA Approves Tablet Formulation of BeOne’s Brukinsa for All Approved Indications
SAN CARLOS, Calif.--(BUSINESS WIRE) Jun 11, 2025 -- BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Are Marathons and Extreme Running Linked to Colon Cancer?

Are Marathons and Extreme Running Linked to Colon Cancer?

DailyTrend Aug 20, 2025  0  0

Congo Has Astronomical Rates of Sexual Violence. Now Vi...

DailyTrend Aug 22, 2025  0  0

The Madden Sisters Don’t Want to Be Institutionalized

The Madden Sisters Don’t Want to Be Institutionalized

DailyTrend Aug 18, 2025  0  0

Was Head-Binding an Ancient Way to Get Ahead?

DailyTrend Aug 22, 2025  0  0

B. Braun Medical Issues Voluntary Nationwide Recall of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL Due to the Presence of Particulate Matter

B. Braun Medical Issues Voluntary Nationwide Recall of ...

DailyTrend Aug 20, 2025  0  0

Wegovy Granted Accelerated Approval in the US for the Treatment of MASH

Wegovy Granted Accelerated Approval in the US for the T...

DailyTrend Aug 18, 2025  0  0